GeneType, Stayhealthy Announce Landmark Distribution Agreement For Multi-Risk Test To A Broader Audience In The Online Pharmacy Channel Across North America
GeneType, Stayhealthy Announce Landmark Distribution Agreement For Multi-Risk Test To A Broader Audience In The Online Pharmacy Channel Across North America
Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, and Stayhealthy, Inc., a leader in health and wellness technology, are excited to announce a major distribution agreement. This partnership will bring GTG's innovative Multi-Risk Test to a broader audience in the online pharmacy channel across North America, empowering individuals to take control of their health.
全球領先的基因技術公司Genetic Technologies Limited（ASX：GTG，納斯達克：GENE，以下簡稱“GTG“）與健康和健身技術領域的領先企業Stayhealthy公司，興奮宣佈達成了一項重大的分銷協議。本合作伙伴關係將會幫助GTG的創新型多風險檢測儀器在北美在線藥房渠道中覆蓋更廣泛的受衆，使個人掌握自己的健康掌控權。
Stayhealthy is at the forefront of integrating technology with health solutions. The company's mission is to empower, inspire, and give hope to individuals, families, and communities through enhanced technology and a global wellness network. Their FDA-cleared technologies have enabled users to measure, track, and improve their health significantly.
Stayhealthy公司是將技術與健康解決方案緊密結合在一起的前沿企業，旨在通過增強技術和全球健康網絡，爲個人、家庭和社區帶來授權、啓發、希望。他們的獲FDA認證的技術使用戶顯著提高了健康的衡量、跟蹤和改善。
